Insider · CIK 0001805812
Mark L. Jacobson
Files at AXSM (Axsome Therapeutics, Inc.). First filing May 28, 2025, latest Sep 3, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AXSM: Axsome Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Axsome Therapeutics, Inc. | $2.1M 10,000 shares | -100% | - | |
| 45Moderate | Axsome Therapeutics, Inc. | $2.8M 25,000 shares | -81% | +37% from low-20% from high | |
| 38Weak | Axsome Therapeutics, Inc. | $4.2M 40,673 shares | -154% | +30% from low-25% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | AXSM Axsome Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +10,000 | $12.95 | $130k | 10,000 | 39 d ago |
| Sep 3, 2026 | AXSM Axsome Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -10,000 | $208.65 | $2.1M | 0 | 39 d ago |
| Sep 3, 2026 | AXSM Axsome Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 104,954 | 39 d ago |
| Jun 9, 2025 | AXSM Axsome Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +25,000 | $8.02 | $201k | 30,783 | Jun 10, 2025 |
| Jun 9, 2025 | AXSM Axsome Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -25,000 | $110.44 | $2.8M | 5,783 | Jun 10, 2025 |
| Jun 9, 2025 | AXSM Axsome Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -25,000 | $0.00 | $0 | 0 | Jun 10, 2025 |
| May 27, 2025 | AXSM Axsome Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +20,673 | $6.47 | $134k | 26,456 | May 28, 2025 |
| May 27, 2025 | AXSM Axsome Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -20,673 | $104.66 | $2.2M | 5,783 | May 28, 2025 |
| May 28, 2025 | AXSM Axsome Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +20,000 | $6.47 | $129k | 25,783 | May 28, 2025 |
| May 28, 2025 | AXSM Axsome Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -20,000 | $103.45 | $2.1M | 5,783 | May 28, 2025 |
| May 27, 2025 | AXSM Axsome Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -20,673 | $0.00 | $0 | 0 | May 28, 2025 |
| May 28, 2025 | AXSM Axsome Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -20,000 | $0.00 | $0 | 0 | May 28, 2025 |
| Feb 21, 2025 | AXSM Axsome Therapeutics, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +10,875 | $0.00 | $0 | 10,875 | Feb 25, 2025 |
| Feb 21, 2025 | AXSM Axsome Therapeutics, Inc. | AGrant or award Restricted Stock Unitsderivative | +10,769 | $0.00 | $0 | 10,769 | Feb 25, 2025 |
| Feb 24, 2025 | AXSM Axsome Therapeutics, Inc. | AGrant or award Performance Stock Unitsderivative | +10,769 | $0.00 | $0 | 10,769 | Feb 25, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.